|
It was reported that, after undergoing right bhr-tha on (b)(6) 2008 due to degenerative osteoarthritis, the patient experienced metallosis along with femoral neck osteolysis.This event was treated with a revision surgery on (b)(6) 2024, during which the modular head and sleeve were removed.A 28mm oxinium femoral head and a 28mmx46mm dual mobility bearing were placed in exchange.Even though there was evidence of osteolysis along the anterior margin of the acetabulum, the cup was retained.This area was debrided without compromising implant fixation and the anterior acetabular wall was bone-grafted.Patient was later transferred to the pacu in stable condition.
|
|
It was reported that patient experienced metallosis along with femoral neck osteolysis.This event was treated with a revision surgery during which the modular head and sleeve were removed.Even though there was evidence of osteolysis along the anterior margin of the acetabulum, the cup was retained.Patient was later transferred to the pacu in stable condition.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the alleged devices was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the cup and none for the head and sleeve.This failure will continue to be monitored for the cup and will continue to be monitored via routine trending for the head and sleeve, however it should be noted that these devices are no longer sold.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.Based on the limited information provided the clinical root cause of the reported elevated metal ions, pseudotumor, and metallosis cannot be confirmed.The patient impact beyond the reported revision could not be determined.Based on the information provided, further investigation of the reported complaint cannot be carried out and remains inconclusive.A definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
|